Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Analyst Rating Guide

News

Back

Repligen Q4 Adjusted EPS $0.33, Inline, Sales $155.74M Beat $155.39M Estimate

Author: Benzinga Newsdesk | February 21, 2024 08:31am

Repligen (NASDAQ:RGEN) reported quarterly earnings of $0.33 per share which met the analyst consensus estimate. This is a 51.47 percent decrease over earnings of $0.68 per share from the same period last year. The company reported quarterly sales of $155.74 million which beat the analyst consensus estimate of $155.39 million by 0.23 percent. This is a 16.61 percent decrease over sales of $186.76 million the same period last year.

Posted In: RGEN